PAMA: CMS Ignores Flawed Processes, Finalizes 2018 PAMA Pricing; Labs Need to Take Immediate Action to Offset Impending Lean Times

摘要

By Kyle Fetter, VP & General Manager of Diagnostic Services, XIFIN, Inc. The final 2018 clinical laboratory fee schedule (CLFS) is out, and it is evident that the argument that the Centers for Medicare & Medicaid Services (CMS) PAMA process was fundamentally flawed fell on deaf ears within CMS. Despite a groundswell urging delay, CMS issued a final clinical lab fee schedule for 2018 that is, with a few exceptions, in line with draft pricing.